Treatment for children with cancer is very intensive, at a time when their young bodies are still growing. That’s why we are 100% committed to funding new and innovative research focused on improving the treatment, diagnosis and prognosis of childhood cancer.
Current research projects
Immunotherapy to fight childhood brain tumours
Over the last year we have funded a £65,000 project, conducted at the Manchester Cancer Research Centre facilities on The Christie campus in south Manchester, to research the use of immunotherapy to treat childhood brain tumours that have a poor prognosis.
The project is investigating the feasibility of using cells called Tumour Infiltrating Lymphocytes (TILs), created by a child’s own immune system, to shrink or destroy brain tumours in children.
Treatment and improved detection of rare bone cancer in children
Our second project, which commenced in July 2017, is researching the treatment and improved detection of osteosarcoma – a rare type of bone cancer that most commonly affects children and young people. There is an urgent requirement to develop novel therapies that target metastatic osteosarcoma. In addition, better detection is pivotal to improving outcomes for children and young people with this form of cancer. If successful, the data obtained during this research could help to greatly improve the detection and treatment of patients with osteosarcoma in the future.
Click here for an project update from lead Friends of Rosie-funded researcher, Dr. Katherine Finegan at The University of Manchester.